Apimeds Pharmaceuticals US, Inc. reports a Return on Equity (ROE) of -32.14%.

What is APUS's dividend yield?

Apimeds Pharmaceuticals US, Inc. offers a dividend yield of 0.00%.

What is APUS's Quality Score?

Our AI rates APUS's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy APUS?

Our AI Timing Score for APUS is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does APUS belong to?

Apimeds Pharmaceuticals US, Inc. is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE MKT exchange

Apimeds Pharmaceuticals US, Inc. (APUS) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

APUS AI Analysis Summary

Our AI summary for APUS: Apimeds Pharmaceuticals US, Inc. (NYSE MKT), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.00, ROE of -32.14%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

APUS

Apimeds Pharmaceuticals US, Inc.

US:NYSE MKT STOCK Healthcare >> Drug Manufacturers - Specialty & Generic

USD 4.65

-0.27 (-5.49%) Day Change

Watchlist Portfolio Compare Chart

0.07

D/E

-32.1%

ROE

-28.8%

ROA

0.00%

Div Yield

APIMEDS PHARMACEUTICALS US, INC.
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 4.65 Price -0.27 (-5.49%) Day Change	NEWS SCORE: N/A

APUS, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.65
PBV / Sector	0.06 / 10.19 GREAT
Earning Per Share	-25.46

PE / Sector	N/A / 31.74
PEG or PE/Growth / Sector	N/A / -0.02
Average 1M Daily Value	0.22 M GREAT
Average 1W Daily Value	0.23 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

47%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 12.63
NPM Average (%) / Sector	N/A / -10.74
NPM Change Average (%) / Sector	N/A / 114.91
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-28.79 / 7.67
ROA Average (%) / Sector	-4,339.57 / 2.97
ROA Change Average (%) / Sector	1,541.77 / 112.43
ROE (%) / Sector	-32.14 / 25.75
ROE Average (%) / Sector	-456.03 / 14.00
ROE Change Average (%) / Sector	-547.73 / 378.64
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.52
Dividend Average (%) / Sector	N/A / 3.06
Dividend Change Average (%) / Sector	N/A / 13.74

Registration Details

Analyze Date	2026-08-06 07:59:38
Symbol	APUS
Name	APIMEDS PHARMACEUTICALS US, INC.
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NYSE MKT
Listed Shares	1.51 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	7.42 / 10,556.24

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 100 Matawan Rd, Matawan, NJ, United States, 07747

Phone: 848 201 5010

Website: https://www.mindwavedao.com

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.